-+ 0.00%
-+ 0.00%
-+ 0.00%

ENHERTU® PLUS PERTUZUMAB APPROVED IN THE U.S. AS FIRST NEW TREATMENT IN MORE THAN A DECADE FOR FIRST-LINE TREATMENT OF PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER

路透·12/15/2025 19:30:00

登錄查看新聞詳情